Glucoză 5% soluţie perfuzabilă Moldova - romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

glucoză 5% soluţie perfuzabilă

ncpc international corp. - glucoza - soluţie perfuzabilă - 5%

Gynipral solutie injectabila 10 mcg/2 ml Moldova - romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

gynipral solutie injectabila 10 mcg/2 ml

nycomed austria gmbh - solutie injectabila - 10 mcg/2 ml

Methylergobrevin solutie injectabila 200 mcg/ml Moldova - romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

methylergobrevin solutie injectabila 200 mcg/ml

hemofarm ad - methylergometrinum - solutie injectabila - 200 mcg/ml

Minirin spray nazal, solutie 10 mcg/doza Moldova - romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

minirin spray nazal, solutie 10 mcg/doza

ferring international center sa - desmopressinum - spray nazal, solutie - 10 mcg/doza

Rinofluimucil spray nazal, solutie 10 mg + 5 mg Moldova - romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

rinofluimucil spray nazal, solutie 10 mg + 5 mg

zambon s.p.a. - acetylcysteinum + tuaminoheptanum - spray nazal, solutie - 10 mg + 5 mg

Apo-Desmopressin Spray spray nazal, solutie 10 mcg/doza Moldova - romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

apo-desmopressin spray spray nazal, solutie 10 mcg/doza

aa pharma inc. - desmopressinum - spray nazal, solutie - 10 mcg/doza

Xylo-nazal 0,1% picături nazale, soluţie Moldova - romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

xylo-nazal 0,1% picături nazale, soluţie

rompharm company srl, sc - xylometazolinum - picături nazale, soluţie - 0,1%

Broncholytin 5,75 mg + 4,6 mg/5 ml sirop Moldova - romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

broncholytin 5,75 mg + 4,6 mg/5 ml sirop

sopharma plc - glaucinum + ephedrinum - sirop - 5,75 mg + 4,6 mg/5 ml

BiResp Spiromax Euroopan unioni - romania - EMA (European Medicines Agency)

biresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

DuoResp Spiromax Euroopan unioni - romania - EMA (European Medicines Agency)

duoresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).